Noninvasive liver fibrosis scores are associated with increased heart failure risk, with FIB-4, NFS, and APRI showing ...

Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to ...

(RTTNews) - Aileron Therapeutics, Inc. (ALRN), Wednesday announced positive topline data from the cohort 2 of Phase 1b study evaluating LTI-03 in patients with idiopathic pulmonary fibrosis (IPF).

Survival rates for idiopathic pulmonary fibrosis are worse than all solid cancers except for lung and pancreatic cancer. | ...

Interstitial lung disease is characterized by scarring (fibrosis) of the lungs and may be life-threatening owing to ...

The development of a novel, artificial intelligence (AI)-generated biotechnology has the potential to transform care options ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...

The UAB Division of Pulmonary, Allergy and Critical Care Medicine is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, ...

Figure 1. Illustration of the measurement plane positions. Left, third intercostal spaces; middle, fourth intercostal spaces; and right, fifth intercostal spaces. The numbers on the electrode belt ...

Spirometry, a type of pulmonary function test (PFT), is a non-invasive procedure ... Intra-thoracic restriction includes diseases of the lung parenchyma, including fibrosis. Sarcoidosis (an ...